Initial Statement of Beneficial Ownership (3)
December 08 2020 - 4:52PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Thom Brian David |
2. Date of Event Requiring Statement (MM/DD/YYYY)
12/1/2020
|
3. Issuer Name and Ticker or Trading Symbol
United Health Products, Inc. [UEEC]
|
(Last)
(First)
(Middle)
10624 S EASTERN AVE., STE A209 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) CEO / |
(Street)
HENDERSON, NV 89052
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock (1) | 125000 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Convertible Notes (2) | 12/1/2020 | 3/31/2021 | Common Stock | 180000 | $0.50 | D | |
Convertible Notes (3) | 12/1/2020 | 3/31/2021 | Common Stock | 800000 | $0.50 | D | |
Restricted Stock Unit Awards | (4) | (4) | Common Stock | 11500000 | (4) | D | |
Explanation of Responses: |
(1) | Excludes restricted stock unit awards totaling 11.5 million shares. |
(2) | Represents services rendered totaling $90,000. |
(3) | Represents cash loans. |
(4) | The restricted stock unit awards vest upon performance and do not contain a conversion or exercise price. 5% of the RSU's vest upon FDA approval of the company's class III PMA, an additional 10% of the RSU's will vest upon the execution of each commercial distribution agreement for the marketing of its products up to a maximum of three such agreements and the balance will vest upon the company achieving $30 million in gross cumulative sales or a covered transaction as defined in the agreement. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Thom Brian David 10624 S EASTERN AVE. STE A209 HENDERSON, NV 89052 |
|
| CEO |
|
Signatures
|
/s/ Brian David Thom | | 12/8/2020 |
**Signature of Reporting Person | Date |
United Health Products (PK) (USOTC:UEEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
United Health Products (PK) (USOTC:UEEC)
Historical Stock Chart
From Apr 2023 to Apr 2024